Global Nuclear Medicine Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global nuclear medicine market in its upcoming report titled, “Global Nuclear Medicine Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global nuclear medicine market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global nuclear medicine market is segmented on the basis of product, application, and region.

Radioactive materials and isotopes used for diagnosis and treatment of diseases such as neurological disorders, cancers, gastrointestinal, heart disease, etc. are known as nuclear medicines. Nuclear medicines help in identification of diseases at an early stage by observing molecular activity of cells within the body.

Increasing prevalence of cancer among individuals across the globe, coupled with increasing demand for accurate diagnosis and effective treatment by use of nuclear medicines are major factors driving growth of the global nuclear medicine market. In addition, increasing investments by governments and private sectors in R&D of nuclear medicines and advanced diagnostic technology and systems is another factor driving growth of the global market.

Major factors hampering growth of the global nuclear medicine market are high cost of diagnostic equipment and high cost of treatment. In addition, stringent government regulations for drug approval and drug usage is another factor hampering growth of the target market. However, increasing application of nuclear medicine in neurological applications is expected to create lucrative opportunities for major manufacturers in the global market over the forecast period.

North America dominates the global nuclear medicine market in terms of revenue and is expected to maintain its dominance over the forecast period. Presence of major manufacturers in this region and increasing investments by private players in R&D of new and advanced diagnostics and treatment technologies and nuclear medicines are major factors contributing for growth of the North America nuclear medicine market. The Europe nuclear medicine market is expected to witness considerable growth and is expected to register a CAGR of X.X% over the next 10 years. The market in Asia Pacific is projected to witness highest growth in terms of revenue, owing to rapid development of healthcare infrastructure in countries such as India, China, etc.

Global Nuclear Medicine Market Segmentation:

Segmentation on the basis of product:

• Diagnostics
  • SPECT
  • PET
• Therapeutics
  • Alpha Emitters
  • Beta Emitters
  • Brachytherapy

Segmentation on the basis of application:

• Diagnostics
  • Cardiology
  • Neurology
  • Oncology
  • Thyroid
  • Lymphoma
  • Others
• Therapeutics
  • Thyroid
  • Bone metastasis
  • Lymphoma
  • Endocrine tumor
  • Others

Segmentation on the basis of region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Cardinal Health Inc.
• Eckert & Ziegler Group
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging S.p.A
• Eczacibasi-Monrol Nuclear Products
• Advanced Accelerator Applications S.A.
• Mallinckrodt Pharmaceuticals
• Jubilant Life Sciences
• NTP Radioisotopes SOC Ltd.